As the first week of 2023 rolled on, the U.S. Food and Drug Administration (FDA) quietly released new rules for the dispersal of the abortion medication mifepristone. The decision has the potential to expand nationwide access to medical abortions through a patient's local pharmacies — should the businesses agree.

A new regulatory change to what is known as the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) Program allows pharmacies, from local businesses to major retailers, to...

Continue Reading Pills for medical abortions can now be dispensed at pharmacies under new FDA rules